Monitoring of circulating tumor DNA predict response to treatment and early progression/relapse in follicular lymphoma: results of a prospective pilot study

In this prospective-based population study, we examined the prognostic value of circulating tumor DNA (ctDNA), before and during treatment, to predict response and early progression in FL patients.